Should the Mini Mental State examination be used to monitor dementia treatments?

Lancet

Volumn 354, Issue 9189, 1999, Pages 1527-1528

  Bowie, Peter ^a   Branton, Tim ^b   Holmes, John ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b High Royds Hospital   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; HUMAN; NORMAL HUMAN; OBSERVER VARIATION; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0033619477     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03486-8     Document Type: Article

References (4)

1. The use of donepezil for Alzheimer's disease. 1998;NHS Executive, London.
2. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res. 12:1975;189-198.
3. Harvey R.J. A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease. Int J Geriatr Psychiatr. 14:1999;249-256.
4. Rogers S.L., Doody R.S., Mohs R.C., Friedhoff L.T. Donepezil improves cognition and global function in Alzheimer's disease: a 15-week, double-blind, placebo-controlled study. Arch Int Med. 158:1998;1021-1031.